InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Explore the full record of transactions filed by POLEWACZYK JAMES F, Directeur Exécutif. Officer active across 1 companies, notably Idexx Laboratories INC /de. In total, 7 reports have been logged. Total volume traded: €5.2m. The latest transaction was disclosed on 14 February 2022 — Levée d'options. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations7 total
0150 shares0
Common Stock
SEC:0001567619-22-004785:0·
€3m4,595 shares@ €560.51520.0048% mcap82.2% of flow
Common Stock
SEC:0001567619-21-021392·
€3m4,595 shares@ €560.51520.0048% mcap41.1% of flow
Common Stock
SEC:0001567619-21-021392:0·
0522 shares0
Common Stock
SEC:0001567619-21-016332·
0522 shares0
Common Stock
SEC:0001567619-21-016332:0·
€556,45810,000 shares@ €55.64580.0010% mcap17.8% of flow
Common Stock
SEC:0001567619-21-011452·
€556,45810,000 shares@ €55.64580.0010% mcap8.9% of flow
Common Stock
SEC:0001567619-21-011452:0·
7 of 7 declarations
About POLEWACZYK JAMES F
POLEWACZYK JAMES F serves as Executive Vice President at IDEXX Laboratories Inc. In this role, he is responsible for managing operations and the company's strategy. His expertise in the sector is essential in supporting growth and innovation.
